Smith Moore & CO. Takes $485,000 Position in UnitedHealth Group Inc (UNH)

Smith Moore & CO. acquired a new position in shares of UnitedHealth Group Inc (NYSE:UNH) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,477 shares of the healthcare conglomerate’s stock, valued at approximately $485,000.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in UNH. Regal Wealth Group Inc. grew its stake in shares of UnitedHealth Group by 0.4% in the 2nd quarter. Regal Wealth Group Inc. now owns 746 shares of the healthcare conglomerate’s stock worth $138,000 after acquiring an additional 3 shares in the last quarter. Jackson Grant Investment Advisers Inc. grew its stake in shares of UnitedHealth Group by 0.4% in the 2nd quarter. Jackson Grant Investment Advisers Inc. now owns 1,101 shares of the healthcare conglomerate’s stock worth $204,000 after acquiring an additional 4 shares in the last quarter. RB Capital Management LLC grew its stake in shares of UnitedHealth Group by 0.4% in the 2nd quarter. RB Capital Management LLC now owns 1,732 shares of the healthcare conglomerate’s stock worth $321,000 after acquiring an additional 7 shares in the last quarter. Highland Private Wealth Management grew its stake in shares of UnitedHealth Group by 0.4% in the 2nd quarter. Highland Private Wealth Management now owns 3,199 shares of the healthcare conglomerate’s stock worth $593,000 after acquiring an additional 13 shares in the last quarter. Finally, RNC Capital Management LLC grew its stake in shares of UnitedHealth Group by 0.7% in the 2nd quarter. RNC Capital Management LLC now owns 1,940 shares of the healthcare conglomerate’s stock worth $360,000 after acquiring an additional 13 shares in the last quarter. Hedge funds and other institutional investors own 86.01% of the company’s stock.

In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,600 shares of the stock in a transaction dated Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the completion of the transaction, the director now owns 61,137 shares in the company, valued at $13,652,503.47. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Thomas E. Roos sold 975 shares of the stock in a transaction dated Thursday, October 19th. The stock was sold at an average price of $205.47, for a total transaction of $200,333.25. Following the transaction, the insider now owns 24,630 shares of the company’s stock, valued at approximately $5,060,726.10. The disclosure for this sale can be found here. Insiders have sold 34,630 shares of company stock valued at $7,669,416 in the last quarter. Company insiders own 0.89% of the company’s stock.

Several research firms have recently issued reports on UNH. Leerink Swann reiterated a “buy” rating and issued a $240.00 target price (up previously from $225.00) on shares of UnitedHealth Group in a research note on Wednesday, October 18th. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 target price for the company in a research note on Thursday, September 21st. Cantor Fitzgerald upped their target price on shares of UnitedHealth Group to $225.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 18th. Oppenheimer upped their target price on shares of UnitedHealth Group from $215.00 to $205.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 18th. Finally, Wells Fargo & Co reiterated an “outperform” rating and issued a $245.00 target price (up previously from $230.00) on shares of UnitedHealth Group in a research note on Wednesday, November 29th. Three equities research analysts have rated the stock with a hold rating and twenty-five have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $226.74.

UnitedHealth Group Inc (NYSE UNH) opened at $224.45 on Friday. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.52. The firm has a market cap of $217,010.00, a PE ratio of 25.51, a P/E/G ratio of 1.52 and a beta of 0.66. UnitedHealth Group Inc has a 1 year low of $156.09 and a 1 year high of $231.77.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping analysts’ consensus estimates of $2.57 by $0.09. The firm had revenue of $50.32 billion during the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The company’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter last year, the business earned $2.17 earnings per share. equities analysts forecast that UnitedHealth Group Inc will post 9.99 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st were given a dividend of $0.75 per share. The ex-dividend date of this dividend was Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a yield of 1.34%. UnitedHealth Group’s dividend payout ratio is presently 34.09%.

ILLEGAL ACTIVITY NOTICE: This news story was originally posted by Ticker Report and is the property of of Ticker Report. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international copyright laws. The correct version of this news story can be viewed at https://www.tickerreport.com/banking-finance/3126664/smith-moore-co-takes-485000-position-in-unitedhealth-group-inc-unh.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


© 2006-2018 Ticker Report. Google+.